International Journal of Medical Laboratory Research (IJMLR)

ASSESSMENT OF PROGESTERONE, CALCIUM, MAGNESIUM AND LIPID PROFILE LEVELS IN FEMALE STUDENTS EXPERIENCING DYSMENORRHEA AT RIVERS STATE UNIVERSITY, NIGERIA.

 

Waribo HA, Okachi GC, Jacob PA, Zorbe BG

 

ABSTRACT:

Background: Dysmenorrhea is a condition characterized by painful menstrual cramps which can significantly impact academic performance and the general quality of life especially in students.  Method: This study aimed at assessing the levels of progesterone, calcium, magnesium and lipid profile among female students at Rivers State University, Port Harcourt, Nigeria. 80 female students were cross sectionally selected, 40 were experiencing dysmenorrhea and 40 were used as the control aged 18-30years.Blood samples were collected at three stages of the menstrual cycle (before, during and after menstruation) to analyze biochemical parameters using validated test methods.  Result: The results showed significant differences in magnesium and progesterone levels before menstruation (P<0.001 and P=0.002 respectively) and in magnesium levels after menstruation (p<0.05) between dysmenorrheic subjects and the controls. Lipid profiles showed phase specific variations with elevated total cholesterol and triglycerides after menstruation in dysmenorrheic subjects which could predispose these students to developing cardiovascular diseases / disorders. Calcium levels were not significantly different across the menstrual phases (p>0.05).  Conclusion: These findings suggest that magnesium and progesterone may have played a critical role in the dysmenorrheic experiences among the students. It highlights the influence of hormonal fluctuations on lipid metabolism. From this study, it is suggested that targeted interventions such as lifestyle changes, dietary modifications, magnesium supplementation may alleviate symptoms associated with dysmenorrhea, reduce menstrual pains and improve the general wellbeing of affected students.

​

Keywords: Dysmenorrhea, Progesterone, Calcium, Magnesium, Lipid Profile, Female Students, Rivers State University

​

​

REFERENCES:​​

1. [1]. Itani R, Soubra L, Karout S, Rahme D, Karout L, Khojah HMJ. Primary dysmenorrhea: pathophysiology, diagnosis, and treatment updates. Korean J Fam Med. 2022;43(2):101–8.

2. [2]. Bahrami A, Avan A, Sadeghnia HR, Esmaeili H, Tayefi M, Ghasemi F, et al. High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents. Gynecol Endocrinol. 2018;34(8):659–63.

3. [3]. Ishikura IA, Hachul H, Tufik S, Andersen ML. Dysmenorrhea and sleep: a review. Sleep Med Clin. 2023;18(4):449–61.

4. [4]. Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36(1):104–13.

5. [5]. Esan DT, Ariyo SA, Akinlolu EF, Akingbade O, Olabisi OI, Olawade DB, et al. Prevalence of dysmenorrhea and its effect on quality of life among female undergraduates in Nigeria. J Endometriosis Uterine Disord. 2024; 5:100059.

6. [6]. Bajalan Z, Moafi F, Moradibaglooei M, Alimoradi Z. Mental health and primary dysmenorrhea: a systematic review. J Psychosom Obstet Gynaecol. 2019;40(3):185–94.

7. [7]. Porri D, Biesalski HK, Limitone A, Bertuzzo L, Cena H. Effect of magnesium supplementation on women's health and well‑being. NFS J. 2021; 23:30–6.

8. [8]. Nelson OE, Beriberi OJ, Waribo HA, Erebi ST, Bodisere LG, Robinson DT, et al. Relationship between blood groups, haemoglobin genotypes and menstrual disorders in female undergraduates in Niger Delta University, Nigeria. Asian Hematol Res J. 2024;7(3):126–36.

9. [9]. Femi‑Agboola DM, Sekoni OO, Goodman OO. Dysmenorrhea and its effects on school absenteeism among adolescents in Ibadan, Nigeria. Niger Med J. 2017; 58:143–8.

10. [10]. Al‑Matouq S, Al‑Mutairi H, Al‑Mutairi O, Abdulaziz F, Al‑Basri D, Al‑Enzi M, Al‑Taiar A. Dysmenorrhea among high‑school students and its associated factors in Kuwait. BMC Pediatr. 2019;19(1):80.

11. [11]. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21(6):762–78.

12. [12]. Durain D. Primary dysmenorrhea: assessment and management update. J Midwif Womens Health. 2004; 49:520–8.

13. [13]. Mrugacz G, Grygoruk C, Sieczynski P, Grusza M, Bolkun L, Pietrewicz P. Etiopathogenesis of dysmenorrhea. Medycyna Wieku Rozwoj. 2013;17(1):85–9.

14. [14]. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Non‑steroidal anti‑inflammatory drugs for dysmenorrhea. Cochrane Database Syst Rev. 2015;(7):CD001751.

15. [15]. Hellman KM, Oladosu FA, Garrison EF, Roth GE, Dillane KE, Tu FF. Circulating sex steroids and bladder pain sensitivity in dysmenorrhea. Mol Pain. 2021; 17:1–11.

16. [16]. Rugvedh P, Gundreddy P, Wandile B. The menstrual cycle's influence on sleep duration and cardiovascular health: a comprehensive review. Cureus. 2023;15(10):e47292.

17. [17]. Liguori S, Moretti A, Paoletta M, Gimigliano F, Iolascon G. Role of magnesium in skeletal muscle health and neuromuscular diseases: a scoping review. Int J Mol Sci. 2024;25(20):11220.

18. [18]. Dai X, Wang Y, Zhang J, Han Y, Liu X. The role of prostaglandin E2 in lipid metabolism and inflammation. Prostagland Other Lipid Mediat. 2014; 113:1–8.

19. [19]. Palmisano BT, Zhu L, Stafford JM. Role of estrogens in regulation of liver lipid metabolism. In: Mauvais‑Jarvis F, editor. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Cham: Springer; 2017. p.1043.

20. [20]. Naz MSG, Kiani Z, Fakari FR, Ghasemi V, Abed M, Ozgoli G. Effect of micronutrients on pain management of primary dysmenorrhea: a systematic review and meta‑analysis. J Caring Sci. 2020;9(1):47–56.

21. [21]. Cavicchia PP, Steck SE, Hurley TG, et al. A new dietary inflammatory index predicts interval changes in serum high‑sensitivity C‑reactive protein. J Nutr. 2009; 139:2365–72.

22. [22]. Yaralizadeh M, Nezamivand‑Chegini S, Najar S, Namjoyan F, Abedi P. Effectiveness of magnesium on menstrual symptoms among dysmenorrheal college students: randomized controlled trial. Int J Womens Health Reprod Sci. 2024;12(2):70–6.

23. [23]. Rahmawati NMM, Maryanto NS, Purbowati N. Correlation between calcium and iron intake with dysmenorrhea in female adolescents in SMA Negeri 1 Ambarawa. J Gizi Kesehat. 2021;13(1):94–103.

24. [24]. Abdi F, Amjadi MA, Zaheri F, Rahnemaei FA. Role of vitamin D and calcium in relief of primary dysmenorrhea: systematic review. Obstet Gynecol Sci. 2021;64(1):13–26.

25. [25]. Thiyagarajan DK, Basit H, Jeanmonod R. Physiology, menstrual cycle. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2024.

26. [26]. Rahman M, Abdullah S, Rahman M, Faruque A. Lipid profile in primary dysmenorrhea. Bangladesh Med J. 2017;46(1):9–13.

27. [27]. Virolainen SJ, VonHandorf A, Viel KCMF, Weirauch MT, Kottyan LC. Gene‑environment interactions and their impact on human health. Genes Immunol. 2023;24(1):1–11.

28. [28]. Vashishta S, Gahlot S, Goyal R. Effect of menstrual cycle phases on plasma lipid and lipoprotein levels in regularly menstruating women. J Clin Diagn Res. 2017;11(5):CC05–7.

29. [29]. Aksoy H, Aksoy U, Aksoy H, Yavuz S. The association of lipid profile with dysmenorrhea in young women. Arch Gynecol Obstet. 2016;294(5):937–43.

30. [30]. Bhattacharjee J, Paul M, Dey S. Association of lipid profile and body mass index with primary dysmenorrhea among medical students. J Family Med Prim Care. 2014;3(1):10–14.

31. [31]. Parazzini F, Chiaffarino F, Lanzi E, Cipriani S. Diet and menstrual pain in young women. Eur J Obstet Gynecol Reprod Biol. 2014; 179:100–3.

32. [32]. Magriplis E, Marakis G, Kotopoulou S, Naska A, Michas G, Micha R, Panagiotakos D, Zampelas A. Trans fatty acid intake increases likelihood of dyslipidemia especially among individuals with higher saturated fat consumption. Rev Cardiovasc Med. 2022;23(4):130.

33. [33]. Maki KC, Dicklin MR, Kirkpatrick CF. Saturated fats and cardiovascular health: Current evidence and controversies. J Clin Lipidol. 2021;15(6):765–72.

34. [34]. Ibekwe PC, Udigwe GO. Relationship between lipid profile and dysmenorrhea in young women in Southeast Nigeria. Niger J Clin Pract. 2019;22(5):1–7.

35. [35]. Adhikaree J, Shrestha R, Bomjan P, et al. Effect of menstrual status on lipid profile: a cross‑sectional study in a tertiary care hospital in Nepal. Post Reprod Health. 2023;29(4):195–200.

36. [36]. Jones D, Judd JT, Taylor PR, Campbell WS, Nair PP. Menstrual cycle effect on plasma lipids. Metabolism. 1988;37(1):1–2.

37. [37]. Mumford SL, Dasharathy S, Pollack AZ, Schisterman EF. Variations in lipid levels according to menstrual cycle phase: clinical implications. Clin Lipidol. 2011;6(2):225–34.

38. [38]. Wazir M, Olanrewaju OA, Yahya M, Kumari J, Kumar N, Singh J, et al. Lipid disorders and cardiovascular risk: a comprehensive analysis of current perspectives. Cureus. 2023;15(12): e51395.

39. [39]. Adeyemi AB, Adekunle DA, Afolabi BA. Menstrual characteristics and prevalence of dysmenorrhea among female medical students in a Nigerian university. J Pain Res. 2018; 11:1–7.

40. [40]. Akinloye O, Oguntibeju OO. Epidemiological review of polycystic ovary syndrome in a South African population. J Gynecol Obstet. 2014;2(4):31–6.

41. [41]. Ozen E, Mihaylova R, Weech M, Kinsella S, Lovegrove JA, Jackson KG. Association between dietary saturated fat with cardiovascular disease risk markers and body composition in healthy adults: findings from BODYCON study. Nutr Metab (Lond). 2022;19(1):15.

42. [42]. Donayeva A, Amanzholkyzy A, Abdelazim I, Saparbayev S, Nurgaliyeva R, Kaldybayeva A, et al. The effects of vitamin D and calcium on primary dysmenorrhea: a systematic review. J Med Life. 2023;16(11):1597–1605.

43. [43]. Carvil P, Cronin J. Magnesium and implications on muscle function. Strength Cond J. 2010;32(5):48–54.

44. [44]. Long S, Romani AM. Role of cellular magnesium in human diseases. Austin J Nutr Food Sci. 2014;2(10):1051.

45. [45]. Lovick TA, Guapo VG, Anselmo‑Franci JA, Loureiro CM, Faleiros MCM, Del Ben CM, et al. A specific luteal‑phase progesterone profile is associated with development of premenstrual symptoms. Psychoneuroendocrinology. 2016; 75:83–90.

46. [46]. Siegburg R, Nilsson CG, Stenman UH, Widholm O. Serum sex hormone levels in adolescent girls with polymenorrhoea. Ann Clin Res. 1987;19(3):183–6.

47. [47]. Strömberg P, Forsling ML, Akerlund M. Effects of prostaglandin inhibition on vasopressin levels in women with primary dysmenorrhea. Obstet Gynecol. 1981;58(2):206–8.

48. [48]. Liedman R, Hansson SR, Howe D, Igidbashian S, McLeod A, Russell RJ, et al. Reproductive hormones over menstrual cycle in primary dysmenorrhea vs healthy subjects. Gynecol Endocrinol. 2008;24(9):508–13.

49. [49]. Taniguchi F, Ota I, Iba Y, Toda T, Tagashira Y, Ohata Y, Kurioka H, Endo Y, Sunada H, Noma H, Azuma Y, Harada T. The efficacy and safety of dydrogesterone for dysmenorrhea: an open‑label multicenter clinical study. J Obstet Gynaecol Res. 2018;45(1):168–75.

50. [50]. Nagy B, Szekeres‑Barthó J, Kovács GL, Sulyok E, Farkas B, Várnagy Á, Vértes V, Kovács K, Bódis J. Key to life: physiological role and clinical implications of progesterone. Int J Mol Sci. 2021;22(20):11039.

51. [51]. Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management. Psychiatry Neurosci. 2000; 25:459–68.